{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:46:18Z","timestamp":1785278778542,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40272-015-0151-3","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T06:27:32Z","timestamp":1448260052000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacologic Management of Pediatric Hypertension"],"prefix":"10.1007","volume":"18","author":[{"given":"Jason","family":"Misurac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen R.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"151_CR1","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114(Supplement 2):555\u201376.","DOI":"10.1542\/peds.114.2.S2.555"},{"issue":"3","key":"151_CR2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamapediatrics.2014.3216","volume":"169","author":"BK Kit","year":"2015","unstructured":"Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999\u20132012. JAMA Pediatr. 2015;169(3):272\u20139.","journal-title":"JAMA Pediatr."},{"issue":"3","key":"151_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.113.3.475","volume":"113","author":"JM Sorof","year":"2004","unstructured":"Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113(3):475\u201382.","journal-title":"Pediatrics"},{"key":"151_CR4","doi-asserted-by":"crossref","unstructured":"McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640\u20134.e1.","DOI":"10.1016\/j.jpeds.2007.01.052"},{"issue":"8","key":"151_CR5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011\u20132012. JAMA. 2014;311(8):806\u201314.","journal-title":"JAMA"},{"issue":"1","key":"151_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1751-7176.2009.00195.x","volume":"12","author":"G Kapur","year":"2010","unstructured":"Kapur G, Ahmed M, Pan C, Mitsnefes M, Chiang M, Mattoo TK. Secondary hypertension in overweight and stage 1 hypertensive children: a midwest pediatric nephrology consortium report. J Clin Hypertens. 2010;12(1):34\u20139.","journal-title":"J Clin Hypertens."},{"issue":"1","key":"151_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ajh.2008.312","volume":"22","author":"Y Ostchega","year":"2009","unstructured":"Ostchega Y, Carroll M, Prineas RJ, McDowell MA, Louis T, Tilert T. Trends of elevated blood pressure among children and adolescents: data from the national health and nutrition examination survey 1988\u20132006. Am J Hypertens. 2009;22(1):59\u201367.","journal-title":"Am J Hypertens"},{"issue":"9","key":"151_CR8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.1990.03450090059025","volume":"264","author":"B Gutin","year":"1990","unstructured":"Gutin B, Charles B, Shea S, Contento I, DeLozier M, Zybert P, et al. Blood pressure, fitness, and fatness in 5- and 6-year-old children. JAMA. 1990;264(9):1123\u20137.","journal-title":"JAMA"},{"issue":"4","key":"151_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1542\/peds.2011-3870","volume":"130","author":"Q Yang","year":"2012","unstructured":"Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics. 2012;130(4):611\u20139.","journal-title":"Pediatrics"},{"issue":"6","key":"151_CR10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpeds.2009.01.015","volume":"154","author":"S Nguyen","year":"2009","unstructured":"Nguyen S, Choi HK, Lustig RH, Hsu C-y. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr. 2009;154(6):807\u201313.","journal-title":"J Pediatr."},{"issue":"4","key":"151_CR11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.112.197525","volume":"60","author":"J Flynn","year":"2012","unstructured":"Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension. 2012;60(4):1047\u201354.","journal-title":"Hypertension"},{"issue":"6","key":"151_CR12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1542\/peds.2007-3432","volume":"122","author":"SJ Swartz","year":"2008","unstructured":"Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122(6):1177\u201381.","journal-title":"Pediatrics"},{"issue":"2","key":"151_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000151623.49780.89","volume":"45","author":"P Verdecchia","year":"2005","unstructured":"Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45(2):203\u20138.","journal-title":"Hypertension"},{"issue":"3","key":"151_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004872-199603000-00009","volume":"14","author":"I Bidlingmeyer","year":"1996","unstructured":"Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens. 1996;14(3):327\u201332.","journal-title":"J Hypertens"},{"issue":"1","key":"151_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2008.01.025","volume":"153","author":"MB Lande","year":"2008","unstructured":"Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. Left ventricular mass index in children with white coat hypertension. J Pediatr. 2008;153(1):50\u20134.","journal-title":"J Pediatr."},{"issue":"3","key":"151_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11906-013-0350-7","volume":"15","author":"E Lurbe","year":"2013","unstructured":"Lurbe E, Torr\u00f3 MI, \u00c1lvarez J. Ambulatory blood pressure monitoring in children and adolescents: coming of age? Curr Hypertens Rep. 2013;15(3):143\u20139.","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"151_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9149(86)90845-3","volume":"57","author":"AP Rocchini","year":"1986","unstructured":"Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol. 1986;57(8):613\u20138.","journal-title":"Am J Cardiol."},{"issue":"5","key":"151_CR18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.112.196980","volume":"60","author":"B Soletsky","year":"2012","unstructured":"Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension. 2012;60(5):1148\u201356.","journal-title":"Hypertension"},{"issue":"8","key":"151_CR19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"D Feig","year":"2008","unstructured":"Feig D, Soletsky B, Johnson R. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300(8):924\u201332.","journal-title":"JAMA"},{"issue":"5","key":"151_CR20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739\u201342.","journal-title":"Kidney Int"},{"issue":"10","key":"151_CR21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00467-007-0537-8","volume":"24","author":"VM Vehaskari","year":"2009","unstructured":"Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol. 2009;24(10):1929\u201337.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"151_CR22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00467-006-0013-x","volume":"21","author":"B Croix","year":"2006","unstructured":"Croix B, Feig D. Childhood hypertension is not a silent disease. Pediatr Nephrol. 2006;21(4):527\u201332.","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"151_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.jhh.1001772","volume":"19","author":"WM Vollmer","year":"2004","unstructured":"Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, Vogt TM, Conlin PR, et al. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens. 2004;19(1):77\u201382.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"151_CR24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"1","key":"151_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archpedi.155.1.50","volume":"155","author":"M Park","year":"2001","unstructured":"Park M, Menard S, Yuan C. Comparison of auscultatory and oscillometric blood pressures. Arch Pediatr Adolesc Med. 2001;155(1):50\u20133.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"151_CR26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0895-7061(95)00334-7","volume":"9","author":"WA Wattigney","year":"1996","unstructured":"Wattigney WA, Webber LS, Lawrence MD, Berenson GS. Utility of an automatic instrument for blood pressure measurement in children: the Bogalusa heart study. Am J Hypertens. 1996;9(3):256\u201362.","journal-title":"Am J Hypertens"},{"issue":"9","key":"151_CR27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","volume":"27","author":"E Lurbe","year":"2009","unstructured":"Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719\u201342.","journal-title":"J Hypertens"},{"issue":"3","key":"151_CR28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1542\/peds.2012-3523","volume":"131","author":"M Thompson","year":"2013","unstructured":"Thompson M, Dana T, Bougatsos C, Blazina I, Norris SL. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics. 2013;131(3):490\u2013525.","journal-title":"Pediatrics"},{"key":"151_CR29","doi-asserted-by":"crossref","unstructured":"Dobson CP, Eide M, Nylund CM. Hypertension prevalence, cardiac complications, and antihypertensive medication use in children. J Pediatr. 2015;167(1):92\u20137.e1.","DOI":"10.1016\/j.jpeds.2015.04.016"},{"issue":"4","key":"151_CR30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.111.085977","volume":"126","author":"J Juhola","year":"2012","unstructured":"Juhola J, Oikonen M, Magnussen CG, Mikkil\u00e4 V, Siitonen N, Jokinen E, et al. Childhood physical, environmental, and genetic predictors of adult hypertension: the Cardiovascular Risk in Young Finns Study. Circulation. 2012;126(4):402\u20139.","journal-title":"Circulation"},{"issue":"3","key":"151_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.113.001614","volume":"128","author":"J Juhola","year":"2013","unstructured":"Juhola J, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium. Circulation. 2013;128(3):217\u201324.","journal-title":"Circulation"},{"key":"151_CR32","doi-asserted-by":"crossref","unstructured":"Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Hypertension. 2008;52(4):631\u20137.","DOI":"10.1161\/HYPERTENSIONAHA.108.110635"},{"issue":"1","key":"151_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344(1):3\u201310.","journal-title":"N Engl J Med"},{"issue":"6","key":"151_CR34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-7176.2012.00656.x","volume":"14","author":"WP Welch","year":"2012","unstructured":"Welch WP, Yang W, Taylor-Zapata P, Flynn JT. Antihypertensive drug use by children: are the drugs labeled and indicated? J Clin Hypertens. 2012;14(6):388\u201395.","journal-title":"J Clin Hypertens."},{"issue":"3","key":"151_CR35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ebch.1974","volume":"9","author":"S Chaturvedi","year":"2014","unstructured":"Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Pharmacological interventions for hypertension in children. Evid Based Child Health. 2014;9(3):498\u2013580.","journal-title":"Evid Based Child Health"},{"issue":"3\u20134","key":"151_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670000480","volume":"15","author":"JT Flynn","year":"2000","unstructured":"Flynn JT, Pasko DA. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol. 2000;15(3\u20134):302\u201316.","journal-title":"Pediatr Nephrol."},{"issue":"8","key":"151_CR37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0091270006289844","volume":"46","author":"JT Flynn","year":"2006","unstructured":"Flynn JT, Nahata MC, Mahan JD, Portman RJ, Investigators P. Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol. 2006;46(8):905\u201316.","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"151_CR38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","volume":"60","author":"M Bullo","year":"2012","unstructured":"Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012;60(2):444\u201350.","journal-title":"Hypertension"},{"issue":"8","key":"151_CR39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/009127002401102786","volume":"42","author":"T Wells","year":"2002","unstructured":"Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 2002;42(8):870\u201380.","journal-title":"J Clin Pharmacol."},{"issue":"3","key":"151_CR40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4274\/Jcrpe.1020","volume":"5","author":"EC Bitkin","year":"2013","unstructured":"Bitkin EC, Boyraz M, Taskin N, Akcay A, Ulucan K, Akyol MB, et al. Effects of ACE inhibitors on insulin resistance and lipid profile in children with metabolic syndrome. J Clin Res Pediatr Endocrinol. 2013;5(3):164\u20139.","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"10","key":"151_CR41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0895-7061(03)00900-2","volume":"16","author":"B Soffer","year":"2003","unstructured":"Soffer B. A double-blind, placebo-controlled, dose\u2013response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 2003;16(10):795\u2013800.","journal-title":"Am J Hypertens"},{"issue":"5","key":"151_CR42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/HJH.0b013e32835f5721","volume":"31","author":"F Schaefer","year":"2013","unstructured":"Schaefer F, Coppo R, Bagga A, Senguttuvan P, Schlosshauer R, Zhang Y, et al. Efficacy and safety of valsartan in hypertensive children 6 months to 5 years of age. J Hypertens. 2013;31(5):993\u20131000.","journal-title":"J Hypertens"},{"issue":"5","key":"151_CR43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/HJH.0b013e328336b86b","volume":"28","author":"F Schaefer","year":"2010","unstructured":"Schaefer F, van de Walle J, Zurowska A, Gimpel C, van Hoeck K, Drozdz D, et al. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6\u00a0years of age. J Hypertens. 2010;28(5):1083\u201390.","journal-title":"J Hypertens"},{"issue":"7","key":"151_CR44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0009922813483875","volume":"52","author":"JE Sullivan","year":"2013","unstructured":"Sullivan JE, Keefe D, Zhou Y, Satlin L, Fang H, Yan J-H. Pharmacokinetics, safety profile, and efficacy of aliskiren in pediatric patients with hypertension. Clin Pediatr. 2013;52(7):599\u2013607.","journal-title":"Clin Pediatr"},{"issue":"15","key":"151_CR45","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","volume":"25","author":"J L\u00f3pez-Send\u00f3","year":"2004","unstructured":"L\u00f3pez-Send\u00f3 J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on \u03b2-adrenergic receptor blockers. Eur Heart J. 2004;25(15):1341\u201362.","journal-title":"Eur Heart J"},{"key":"151_CR46","doi-asserted-by":"crossref","unstructured":"Batisky DL, Sorof JM, Sugg J, Llewellyn M, Klibaner M, Hainer JW, et al. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. J Pediatr. 2007;150(2):134\u20139.e1.","DOI":"10.1016\/j.jpeds.2006.09.034"},{"key":"151_CR47","doi-asserted-by":"crossref","unstructured":"Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, et al. \u03b2-Blocker\/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 2002;17(5):345\u201350.","DOI":"10.1007\/s00467-002-0851-0"},{"key":"151_CR48","unstructured":"Okeke CCP, Medwick TPD, Nairn GP, Khuspe SB, Grady LTP. Stability of hydralazine hydrochloride in both flavored and nonflavored extemporaneous preparations. Int J Pharm Compd. 2003;7(4):313\u20139."},{"issue":"1","key":"151_CR49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1468-6708-3-10","volume":"3","author":"L Piller","year":"2002","unstructured":"Piller L, Davis B, Cutler J, Cushman W, Wright J, Williamson J, et al. Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants assigned to doxazosin and chlorthalidone. Curr Control Trials Cardiovasc Med. 2002;3(1):10.","journal-title":"Curr Control Trials Cardiovasc Med."},{"issue":"6","key":"151_CR50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00467-008-1000-1","volume":"24","author":"J Flynn","year":"2009","unstructured":"Flynn J, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol. 2009;24(6):1101\u201312.","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"151_CR51","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.jash.2014.03.300","volume":"8","author":"J Flynn","year":"2014","unstructured":"Flynn J, Bradford M, Harvey E. Intravenous (IV) hydralazine in hypertensive pediatric inpatients: does it work? Is it safe? J Am Soc Hypertens. 2014;8(4):e130.","journal-title":"J Am Soc Hypertens."},{"issue":"10","key":"151_CR52","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00467-007-0573-4","volume":"24","author":"M Lande","year":"2009","unstructured":"Lande M, Flynn J. Treatment of hypertension in children and adolescents. Pediatr Nephrol. 2009;24(10):1939\u201349.","journal-title":"Pediatr Nephrol."},{"key":"151_CR53","unstructured":"Clonidine: Pediatric drug information. Pediatric Lexi-Drugs Online [Internet]. Hudson (OH): Lexi-Comp, Inc.; 1978\u20132013."},{"key":"151_CR54","unstructured":"Amlodipine. Drugdex System. New York: Thompson Reuters (Healthcare) Inc; 2013 (Updated Periodically)."},{"key":"151_CR55","unstructured":"Chlorothiazide: Pediatric drug information. Pediatric Lexi-Drugs Online [Internet]. Hudson (OH): Lexi-Comp, Inc.; 1978\u20132013."},{"issue":"5","key":"151_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"issue":"19","key":"151_CR57","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372.","journal-title":"JAMA"},{"key":"151_CR58","unstructured":"Valsartan: Pediatric drug information. Pediatric Lexi-Drugs Online [Internet]. Hudson (OH): Lexi-Comp, Inc.; 1978\u20132013."},{"issue":"4","key":"151_CR59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3476(05)80711-5","volume":"117","author":"TG Wells","year":"1990","unstructured":"Wells TG, Bunchman TE, Kearns GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr. 1990;117(4):664\u20137.","journal-title":"J Pediatr"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0151-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-015-0151-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0151-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:48Z","timestamp":1559490288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-015-0151-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1007\/s40272-015-0151-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}